Effects of Sorafenib on <em>C</em>-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells

Recent evidence suggests that the development of castration resistant prostate cancer (CRPCa) is commonly associated with an aberrant, ligand-independent activation of the androgen receptor (AR). A putative mechanism allowing prostate cancer (PCa) cells to grow under low levels of androgens, is the...

Full description

Bibliographic Details
Main Authors: Mark Schrader, Bianca Nitzsche, Michael Höpfner, Marcus V. Cronauer, Andres J. Schrader, Friedemann Zengerling, Wolfgang Streicher
Format: Article
Language:English
Published: MDPI AG 2012-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/13/9/11530